Cell-based therapy holds great potential to address unmet medical needs and revolutionize
the healthcare industry, as demonstrated by several therapeutics such as CAR-T cell …

NK cells are the major lymphocyte subset of the innate immune system that mediates
antiviral and anti-tumor responses. It is well established that they develop mechanisms to …

Cell-based drug delivery systems (DDSs) have received attention recently because of their
unique biological properties and self-powered functions, such as excellent biocompatibility …

Some specific chemotherapeutic drugs are able to enhance tumor immunogenicity and
facilitate antitumor immunity by inducing immunogenic cell death (ICD). However, tumor …

Numerous clinical trials for cancer precision medicine research are limited due to the drug
resistance, side effects, and low efficacy. Unsatisfactory outcomes are often caused by …

Cancer immunotherapy involves a cascade of events that ultimately leads to cytotoxic
immune cells effectively identifying and destroying cancer cells. Responsive nanomaterials …

Macrophages hold great potential in cancer drug delivery because they can sense
chemotactic cues and home to tumors with high efficiency. However, it remains a challenge …

Immune cells are attractive targets for therapy as they are direct participants in a variety of
diseases. Delivering a therapeutic agent only to cells that act on a disease by distinguishing …

The past decade has witnessed the explosive development of cancer immunotherapies.
Nevertheless, low immunogenicity, limited specificity, poor delivery efficiency, and off‐target …

Cancer immunotherapy has emerged as a promising strategy for the treatment of many
forms of cancer by stimulating body's own immune system. This therapy not only eradicates …